Aim: We sought to examine attenuated first-rank symptoms (FRS) and subcomponents of the Unusual Thought Content (P.1.) section of the Structured Interview for Psychosis-Risk Syndromes (SIPS) to investigate the robust relationship between total P.1. and conversion. We hypothesized that attenuated FRS would drive the association and, additionally, be most predictive of a schizophrenia diagnosis.
the SIPS is significantly predictive of transition to psychosis (Addington et al., 2015; Cannon et al., 2016) , and has demonstrated external validity in other samples (Carrión et al., 2016; Ruhrmann et al., 2010) , including our own (Brucato et al., 2017) .
However, as P.1. captures a number of positive symptoms, we sought to clarify which subcomponent drives this relationship. Moreover, we wished to examine the relationship between attenuated FRS (voices conversing, voices commenting, thought echo, somatic hallucinations, thought broadcasting, mind being read, delusional perception, delusion of control or passivity) and conversion. We hypothesized that attenuated FRS would specifically predict an outcome diagnosis of schizophrenia, among those who developed psychosis.
| METHOD

| Subjects
We recruited 189 help-seeking CHR participants through health care providers, clinicians and self-referrals. Following telephone screening, potential participants completed in-person eligibility evaluations.
Inclusion criteria were: (1) age 13 to 30 year old; (2) capacity for informed consent or assent; (3) English-speaking and (4) meeting psychosis-risk criteria defined by the SIPS. All participants met for the APSS, defined by the presence of 1 or more attenuated positive symptoms of sufficient severity for at least once per week in the past month. Exclusion criteria included: (1) past or present full-blown psychosis; (2) a nervous system disorder; (3) I.Q. <70; (4) moderate or severe risk of harm to self or others; and/or (5) current substance abuse or dependence. Adults provided written informed consent, while minors provided written assent alongside parental informed consent. This study was approved by the Institutional Review Board of the New York State Psychiatric Institute at Columbia University Medical Center.
| Clinical assessment
CHR participants were assessed at baseline using version 5.3 the SIPS (McGlashan et al., 2013) , a semi-structured interview including 5 positive, 6 negative, 4 disorganized and 4 general symptom subscales, individually rated from 0 to 6 (absent to severe). The attenuated range for positive symptoms includes scores from 3 to 5. Based upon detailed vignettes and rater comments collected via the baseline SIPS, 2 certified SIPS raters independently assigned scores for attenuated FRS, and the 5 subcomponents of P.1. using SIPS scoring methods with above 90% interrater reliability. The details of each vignette are written so that raters can independently assess each symptom category, therefore each rater was given his or her own version of the vignettes, and scored separately. Then, raters met to attain a reliable rating through consensus. Agreed-upon scores of attenuated FRS and P.1. subcomponents were used for analyses. Participants were evaluated approximately every 3 months, for up to 2 years, to determine possible conversion.
| Statistical analyses
Descriptive statistics, mean differences in baseline demographics and clinical features between converters and non-converters were derived using t-tests, Chi-squared tests, and Mann-Whitney U tests.
Fisher's exact test was used, where warranted by low cell counts.
Logistic regression was used to confirm prediction models. Survival analysis was used to predict days to conversion (cox proportional hazards regression). An alpha level of P < .05 was considered significant.
| RESULTS
The overall CHR sample was young (M = 20.16 year, SD = 3.74 year), predominantly male (68.7%), and ethnically and racially diverse (30% Hispanic, 20.9% African American and 5.2% Asian American). Of the 36.3% of participants taking medication at baseline, 8.9% were prescribed antipsychotic medication, 14.5% antidepressants and 12.8%
were prescribed a combination of both. Converters comprised 28.6% of the sample. Of those that converted, 64.8% received a schizophrenia diagnosis. No demographic differences between converters and non-converters were noted (Table 1) . Attenuated FRS were analysed using t-tests, Mann-Whitney U tests, and logistic regression to predict conversion. Due to lack of variability in voices conversing, thought echo, thought broadcasting and mind being read, they were excluded from further analyses (less than 3 subjects with a score other than 0). Of those included (voices commenting, somatic hallucinations, delusional perception, delusion of control/passivity), t-tests for each individual attenuated FRS showed no differences by conversion status. Logistic regression showed trend-level significance for voices commenting (β = 1.07, P = .07) but non-significant results for the rest; however, results became non-significant when demographic variables were included in the model (all P > .9). A Cox proportional hazards regression model censoring non-convertors for days to conversion was similarly not significant for this or any other attenuated FRS (all P > .12 not including demographic variables and all P > .13 including them).
The means and SDs for the 5 subcomponents of P.1. from the SIPS and attenuated FRS are presented in Table 2 . The t-tests identified no significant differences in P.1. subcomponent scores between converters and non-converters; however, a significant difference in total P.1. score (P = .003) was observed, as expected. To further explore whether baseline scores on the P.1. subcomponents predict conversion to psychosis, we performed logistic regression, including scores from the 5 subcomponents in the model. Results indicated that none of the 5 P.1. subcomponents were independently predictive of conversion (Table 2) . Results remained non-significant, even when including demographic variables and other SIPS symptoms.
To determine whether baseline first-rank scores differed among converters to schizophrenia vs converters to other psychotic disorders, we performed t-tests between the 2 groups. None of the attenuated FRS showed significant effects (all P > .21). No significant differences were observed in P.1. first-rank subscore (P = .19). Logistic regression showed similar results with models based on attenuated FRS and P.1. subcomponents (all P > .05). Results were nonsignificant after including other SIPS symptoms and demographic variables.
| DISCUSSION
In our sample, neither the presence of attenuated FRS nor the 5 subcomponents of P.1. independently predicted transition to psychosis.
Although the attenuated FRS, voices commenting, has trend-level significance, this finding would unlikely survive any correction for multiple comparisons given the various tests performed, and that the focus was on delusions, and not hallucinations. We also found that Non-converters (n = 135, 71.4%) Converters (n = 54, 28.6%%; schizophrenia diagnosis n = 35, 64.8%)
Total P1 score 3.41 (1.05); n = 133 3.93 (1.06) P = .003
P1 subscales (n of subjects scored ≥3)
1. Perplexity and delusional mood (115) 2.67 (1.11) 2.80 (1.17) β = 0.14, P = .41 FRS may drive this predictive relationship (note that despite the trend effect observed for voices commenting, this symptom cannot drive the P.1. effect because it is related to perceptual disturbances, and not unusual thought content). A possible explanation could be that since overall severity regardless of specific attenuated delusional ideation is what determines total score on P.1., these symptoms as a whole may contribute to conversion, and may have substantial variability across individuals and symptoms.
A wide variety of symptoms is captured under the umbrella of P.1. on the SIPS. Our attempt to examine attenuated FRS by disentangling singular contributions of P.1. subcomponents on transition to psychosis was novel, in that each subcomponent was individually scored and evaluated to understand the underlying factors which might drive the strong association between total P.1. and transition to psychosis reported in the literature (Addington et al., 2015; Brucato et al., 2017; Cannon et al., 2016; Carrión et al., 2016; Ruhrmann et al., 2010) Notably, while the sample size is relatively large for a population that is characteristically difficult to recruit, it remains modest for phenomenological research. In addition, the current study was a secondary analysis performed with the goal of generating hypotheses about subcomponents of P.1. of the SIPS, and primarily FRS. While our sample of 189 CHR subjects is one of the largest single-site CHR cohorts available, variability in attenuated FRS was low; therefore, these results will need to be replicated and confirmed in a larger cohort, specifically powered to examine these questions. Future research should focus on identifying more specific patterns of symptoms, ideally strongly associated with biomarkers, to elucidate possible strategies to better predict transition to psychosis so that early intervention programmes can more effectively tailor treatment.
